Grants and Contracts Details
Topical tacrolimus will reduce tissue targeted postoperative inflammation following placement of a drainage device in glaucoma patients and result in improved outcomes. This prospective pilot project will be designed to evaluate the surgical outcomes in consecutive glaucoma patients randomized to either the standard postoperative medication regimen or treatment with topical tacrolimus.
|Effective start/end date||3/1/15 → 3/31/19|
- American Glaucoma Society Foundation: $40,000.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.